API Urofollitropin FSH is a highly purified active pharmaceutical ingredient used in reproductive medicine to treat infertility in both women and men. It is a naturally derived form of follicle-stimulating hormone (FSH) that closely resembles the hormone produced by the human pituitary gland, regulating reproductive function.

• CAS Number: 97048-13-0
• Standards: In-House / IP / EP / BP

Manufactured under strict quality control, Urofollitropin API ensures safety, purity, and consistency for pharmaceutical formulation and clinical use.

Mechanism of Action

Urofollitropin stimulates ovarian follicle growth in women and supports sperm production in men. By mimicking natural FSH activity, it regulates reproductive hormone signaling and enhances fertility processes.

Applications in Female Fertility Treatment

In women, Urofollitropin FSH promotes controlled ovarian stimulation, supporting follicular development and ovulation. It is especially beneficial for patients with ovulatory disorders, irregular cycles, or unexplained infertility.

Role in Assisted Reproductive Technologies (ART)

Used in assisted reproductive techniques such as:

Its precise activity helps clinicians optimize follicle development and improve pregnancy success rates.

Applications in Male Fertility

In men, Urofollitropin treats hypogonadotropic hypogonadism, where insufficient pituitary stimulation reduces testosterone and sperm production. It restores spermatogenesis and improves reproductive function.

Dosage and Administration

Administered via subcutaneous or intramuscular injection, treatments involve daily dosing with monitoring through ultrasounds and hormonal blood tests to ensure effective follicular development and patient safety.

Safety and Monitoring

Use only under qualified healthcare supervision. Monitoring minimizes risks such as ovarian hyperstimulation syndrome (OHSS) and multiple pregnancies.

Conclusion

API Urofollitropin FSH is a vital component of modern fertility medicine. Its high purity, proven efficacy, and compliance with pharmacopoeial standards make it a preferred choice for pharmaceutical manufacturers and fertility clinics. Controlled and responsible use supports successful reproductive outcomes worldwide.